DSpace Repository

Prescribing Pattern for Covid 19 Positive Patients in Bangladesh

Show simple item record

dc.contributor.author Hossen, Toufiq
dc.date.accessioned 2022-10-27T03:12:11Z
dc.date.available 2022-10-27T03:12:11Z
dc.date.issued 2021-12
dc.identifier.uri http://dspace.daffodilvarsity.edu.bd:8080/handle/123456789/8797
dc.description.abstract Corona virus diseases 2019 commonly known as (Covid 19) caused by SARS-CoV-2, is a life threatening highly infectious severe acute respiratory syndrome. It has been associated with increased mortality all over the world. Many treatment guidelines had been adopted to cure or prevent Covid 19 infections. This study is conducted with a view to go through the scholarly articles to get an overall idea about the drugs used across the globe during the pandemic to manage covid infected patients. Most cases hospital admission was not required. However, from the literature review it is found that various types of drugs were administered including antiviral, antibiotics, antimalarial, vaccine, anti-coagulant drugs, anti- histamine. On the other side, based on the prescription survey it is noticed that ivermectin, moxifloxacin, levofloxacin, some steroid, tocilizumab, rivaroxaban were prescribed to reduce covid induced complications. But in the study, it remained unclear why Ivermectin alone or with other antibiotics were mostly given to the covid positive patients in the study area of Bangladesh whereas use of Ivermectin was limited in the other countries. Further research may be conducted to find out the plausible reasons behind this. en_US
dc.language.iso en_US en_US
dc.publisher Daffodil International University en_US
dc.subject COVID-19 (Disease) en_US
dc.subject Antibiotics en_US
dc.subject Ivermectin en_US
dc.title Prescribing Pattern for Covid 19 Positive Patients in Bangladesh en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account